WO2003087341A2
(en)
|
2002-01-23 |
2003-10-23 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
US20030232410A1
(en)
*
|
2002-03-21 |
2003-12-18 |
Monika Liljedahl |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
EP2806025B1
(en)
|
2002-09-05 |
2019-04-03 |
California Institute of Technology |
Use of zinc finger nucleases to stimulate gene targeting
|
WO2005014791A2
(en)
*
|
2003-08-08 |
2005-02-17 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP1678315B1
(en)
|
2003-09-19 |
2011-08-03 |
Sangamo BioSciences, Inc. |
Engineered zinc finger proteins for regulation of gene expression
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
CA2579677A1
(en)
|
2004-09-16 |
2006-03-30 |
Sangamo Biosciences, Inc. |
Compositions and methods for protein production
|
AU2012245168B2
(en)
*
|
2005-07-26 |
2014-12-11 |
Sangamo Therapeutics, Inc. |
Targeted Integration and Expression of Exogenous Nucleic Acid Sequences
|
CN101273141B
(zh)
*
|
2005-07-26 |
2013-03-27 |
桑格摩生物科学股份有限公司 |
外源核酸序列的靶向整合和表达
|
EP2484758B1
(en)
|
2005-10-18 |
2013-10-02 |
Precision Biosciences |
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
|
US20070154989A1
(en)
*
|
2006-01-03 |
2007-07-05 |
The Scripps Research Institute |
Zinc finger domains specifically binding agc
|
US20070266449A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Zivin Robert A |
Generation of animal models
|
CA2650414A1
(en)
*
|
2006-05-19 |
2007-11-29 |
Sangamo Biosciences, Inc. |
Methods and compositions for inactivation of dihydrofolate reductase
|
EP2019839B1
(en)
|
2006-05-25 |
2011-12-07 |
Sangamo BioSciences, Inc. |
Methods and compositions for gene inactivation
|
DE602007005634D1
(de)
|
2006-05-25 |
2010-05-12 |
Sangamo Biosciences Inc |
Variante foki-spaltungshälften-domänen
|
AU2007284748B2
(en)
|
2006-08-11 |
2013-05-16 |
Corteva Agriscience Llc |
Zinc finger nuclease-mediated homologous recombination
|
US9217026B2
(en)
*
|
2006-11-13 |
2015-12-22 |
Sangamo Biosciences, Inc. |
Method of inactivating a glucocorticoid receptor gene in an isolated cell
|
MX2009006303A
(es)
|
2006-12-14 |
2009-10-21 |
Dow Agrosciences Llc |
Proteinas de dedo de zinc no canonicas optimizadas.
|
US8748146B2
(en)
*
|
2007-04-19 |
2014-06-10 |
Celexion, Llc |
Engineered nucleases and their uses for nucleic acid assembly
|
DE602008003684D1
(de)
|
2007-04-26 |
2011-01-05 |
Sangamo Biosciences Inc |
Gezielte integration in die ppp1r12c-position
|
WO2008153742A2
(en)
*
|
2007-05-23 |
2008-12-18 |
Sangamo Biosciences, Inc. |
Methods and compositions for increased transgene expression
|
EP2568048A1
(en)
|
2007-06-29 |
2013-03-13 |
Pioneer Hi-Bred International, Inc. |
Methods for altering the genome of a monocot plant cell
|
JP5770471B2
(ja)
*
|
2007-07-12 |
2015-08-26 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
α−1,6−フコシルトランスフェラーゼ(FUT8)遺伝子発現を不活性化するための方法および組成物
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
WO2009042186A2
(en)
*
|
2007-09-27 |
2009-04-02 |
Sangamo Biosciences, Inc. |
Genomic editing in zebrafish using zinc finger nucleases
|
CN101883863B
(zh)
*
|
2007-09-27 |
2018-01-23 |
桑格摩生物科学股份有限公司 |
生物活性核酸酶的快速体内鉴定
|
US8399218B2
(en)
|
2007-09-27 |
2013-03-19 |
Dow Agrosciences, Llc |
Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes
|
CA2703045C
(en)
*
|
2007-10-25 |
2017-02-14 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted integration
|
CA2703079A1
(en)
*
|
2007-12-07 |
2009-06-18 |
Precision Biosciences, Inc. |
Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
|
WO2009114321A2
(en)
*
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
JP2011518555A
(ja)
|
2008-04-14 |
2011-06-30 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
標的組込みのための線形ドナーコンストラクト
|
WO2009146179A1
(en)
*
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
AU2009241351A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Precision Biosciences, Inc. |
Fusion molecules of rationally-designed DNA-binding proteins and effector domains
|
JP2011527906A
(ja)
|
2008-07-14 |
2011-11-10 |
プレシジョン バイオサイエンシズ,インク. |
I−CreI由来メガヌクレアーゼの認識配列およびその使用
|
KR101759586B1
(ko)
|
2008-08-22 |
2017-07-19 |
상가모 테라퓨틱스, 인코포레이티드 |
표적화된 단일가닥 분할 및 표적화된 통합을 위한 방법 및 조성물
|
EP2180058A1
(en)
*
|
2008-10-23 |
2010-04-28 |
Cellectis |
Meganuclease recombination system
|
US8153399B2
(en)
|
2008-10-29 |
2012-04-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for inactivating glutamine synthetase gene expression
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
US20110023159A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Ovine genome editing with zinc finger nucleases
|
CA2745031C
(en)
*
|
2008-12-04 |
2018-08-14 |
Sangamo Biosciences, Inc. |
Genome editing in rats using zinc-finger nucleases
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
US20110016542A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Canine genome editing with zinc finger nucleases
|
US20110023157A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Equine genome editing with zinc finger nucleases
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
BRPI0922641B1
(pt)
*
|
2008-12-17 |
2021-10-26 |
Dow Agrosciences Llc |
Método de integração de uma ou mais sequências de ácido nucleico exógenas no genoma de uma célula vegetal
|
EP2408921B1
(en)
*
|
2009-03-20 |
2017-04-19 |
Sangamo BioSciences, Inc. |
Modification of cxcr4 using engineered zinc finger proteins
|
WO2010117464A1
(en)
|
2009-04-09 |
2010-10-14 |
Sangamo Biosciences, Inc. |
Targeted integration into stem cells
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
CA2765488C
(en)
*
|
2009-06-30 |
2018-01-02 |
Sangamo Biosciences, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
CA2766123A1
(en)
|
2009-07-08 |
2011-01-13 |
Cellular Dynamics International, Inc. |
Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene
|
CN102858985A
(zh)
*
|
2009-07-24 |
2013-01-02 |
西格马-奥尔德里奇有限责任公司 |
基因组编辑方法
|
JP2013500018A
(ja)
*
|
2009-07-24 |
2013-01-07 |
シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニー |
ゲノム編集のための方法
|
EP2461819A4
(en)
|
2009-07-28 |
2013-07-31 |
Sangamo Biosciences Inc |
METHODS AND COMPOSITIONS FOR TREATING TRI-NUCLEOTIDE REPEAT DISORDERS
|
CA2770312A1
(en)
*
|
2009-08-11 |
2011-02-17 |
Sangamo Biosciences, Inc. |
Organisms homozygous for targeted modification
|
WO2011051390A1
(en)
*
|
2009-10-28 |
2011-05-05 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Homologous recombination in the oocyte
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
WO2011078662A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Keygene N.V. |
Dsrna for improved genetic modification of plant dna
|
CA2787494C
(en)
*
|
2010-01-22 |
2019-09-17 |
Dow Agrosciences Llc |
Targeted genomic alteration
|
KR101951489B1
(ko)
*
|
2010-01-22 |
2019-04-22 |
다우 아그로사이언시즈 엘엘씨 |
유전적으로 변형된 유기체에서 도입유전자의 절제
|
WO2011091324A2
(en)
*
|
2010-01-22 |
2011-07-28 |
The Scripps Research Institute |
Methods of generating zinc finger nucleases having altered activity
|
AU2011213242B2
(en)
|
2010-02-08 |
2015-01-29 |
Sangamo Therapeutics, Inc. |
Engineered cleavage half-domains
|
WO2011100058A1
(en)
|
2010-02-09 |
2011-08-18 |
Sangamo Biosciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
BR112012027532A2
(pt)
|
2010-04-26 |
2020-10-13 |
Sangamo Biosciences, Inc. |
edição de genoma de um locus rosa usando nucleases de dedo de zinco.
|
WO2011146121A1
(en)
|
2010-05-17 |
2011-11-24 |
Sangamo Biosciences, Inc. |
Novel dna-binding proteins and uses thereof
|
CA2993567C
(en)
|
2010-07-21 |
2022-06-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of a t-cell receptor gene
|
CN103168101A
(zh)
*
|
2010-07-23 |
2013-06-19 |
西格马-奥尔德里奇有限责任公司 |
使用靶向核酸内切酶和单链核酸的基因组编辑
|
WO2012018726A1
(en)
*
|
2010-08-02 |
2012-02-09 |
Cellectis Sa |
Method for increasing double-strand break-induced gene targeting
|
US9566352B2
(en)
|
2010-09-27 |
2017-02-14 |
Sangamo Biosciences, Inc. |
Methods and compositions for inhibiting viral entry into cells
|
ES2562421T3
(es)
|
2010-10-12 |
2016-03-04 |
The Children's Hospital Of Philadelphia |
Métodos y composiciones para tratar la hemofilia B
|
US9121059B2
(en)
|
2010-12-22 |
2015-09-01 |
Genia Technologies, Inc. |
Nanopore-based single molecule characterization
|
WO2012094132A1
(en)
|
2011-01-05 |
2012-07-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene correction
|
CN102174649B
(zh)
*
|
2011-01-18 |
2013-06-12 |
陕西师范大学 |
快速检测锌指核酸酶介导基因定点整合的方法
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
US10920242B2
(en)
|
2011-02-25 |
2021-02-16 |
Recombinetics, Inc. |
Non-meiotic allele introgression
|
CN102206631A
(zh)
*
|
2011-03-08 |
2011-10-05 |
西北农林科技大学 |
一种开源方式筛选靶向结合人dyrk1a基因靶位点的锌指蛋白的方法
|
CN102358902B
(zh)
*
|
2011-04-02 |
2013-01-02 |
西南大学 |
家蚕丝素重链基因突变序列及突变的方法和应用
|
WO2012152912A1
(en)
|
2011-05-12 |
2012-11-15 |
Newvectys |
Genetically modified pig as a cancer prone model
|
EP2857506A3
(en)
|
2011-06-08 |
2015-04-29 |
Miedzynarodowy Instytut Biologii Molekularnej I Komorkowej |
Sequence-specific engineered ribonuclease H and the method for determining the sequence preference of DNA-RNA hybrid binding proteins
|
EP2737063B1
(en)
|
2011-07-25 |
2016-06-01 |
Sangamo BioSciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
AU2012312260B2
(en)
|
2011-09-21 |
2017-08-31 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of transgene expression
|
CA3099582A1
(en)
|
2011-10-27 |
2013-05-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the hprt locus
|
JP6144691B2
(ja)
|
2011-11-16 |
2017-06-07 |
サンガモ セラピューティクス, インコーポレイテッド |
修飾されたdna結合タンパク質およびその使用
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
BR112014021104B1
(pt)
|
2012-02-29 |
2023-03-28 |
Sangamo Biosciences, Inc |
Proteína de fusão de ocorrência não natural compreendendo um domínio de ligação de dna de dedo de zinco manipulado que se liga a um gene htt, seu uso, método in vitro de modificação da expressão de um gene htt em uma célula, e método de geração de um sistema modelo para o estudo da doença de huntington
|
PL2847335T3
(pl)
|
2012-04-25 |
2019-01-31 |
Regeneron Pharmaceuticals, Inc. |
Celowanie dużymi wektorami do celowania wspomagane nukleazą
|
NZ701060A
(en)
*
|
2012-05-02 |
2016-10-28 |
Sangamo Biosciences Inc |
Targeted modification of malate dehydrogenase
|
RU2650819C2
(ru)
|
2012-05-07 |
2018-04-17 |
Сангамо Терапьютикс, Инк. |
Способы и композиции для опосредованной нуклеазой направленной интеграции трансгенов
|
DE202013012242U1
(de)
|
2012-05-25 |
2016-02-02 |
Emmanuelle Charpentier |
Zusammensetzungen für die durch RNA gesteuerte Modifikation einer Ziel-DNA und für die durch RNA gesteuerte Modulation der Transkription
|
WO2013188841A1
(en)
|
2012-06-15 |
2013-12-19 |
Genia Technologies, Inc. |
Chip set-up and high-accuracy nucleic acid sequencing
|
CA2877290A1
(en)
|
2012-06-19 |
2013-12-27 |
Daniel F. Voytas |
Gene targeting in plants using dna viruses
|
JP6329537B2
(ja)
|
2012-07-11 |
2018-05-23 |
サンガモ セラピューティクス, インコーポレイテッド |
生物学的薬剤の送達のための方法および組成物
|
US10648001B2
(en)
*
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
WO2014011237A1
(en)
*
|
2012-07-11 |
2014-01-16 |
Sangamo Biosciences, Inc. |
Methods and compositions for the treatment of lysosomal storage diseases
|
US10058078B2
(en)
|
2012-07-31 |
2018-08-28 |
Recombinetics, Inc. |
Production of FMDV-resistant livestock by allele substitution
|
KR102218562B1
(ko)
|
2012-08-29 |
2021-02-19 |
상가모 테라퓨틱스, 인코포레이티드 |
유전적 병태를 치료하기 위한 방법 및 조성물
|
CN105264067B
(zh)
*
|
2012-09-07 |
2020-11-10 |
美国陶氏益农公司 |
Fad3性能基因座及相应的能够诱导靶向断裂的靶位点特异性结合蛋白
|
UA118090C2
(uk)
|
2012-09-07 |
2018-11-26 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб інтегрування послідовності нуклеїнової кислоти, що представляє інтерес, у ген fad2 у клітині сої та специфічний для локусу fad2 білок, що зв'язується, здатний індукувати спрямований розрив
|
UA119135C2
(uk)
|
2012-09-07 |
2019-05-10 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб отримання трансгенної рослини
|
AU2013329186B2
(en)
|
2012-10-10 |
2019-02-14 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
US9605309B2
(en)
|
2012-11-09 |
2017-03-28 |
Genia Technologies, Inc. |
Nucleic acid sequencing using tags
|
CN103215234B
(zh)
*
|
2012-11-09 |
2014-12-10 |
陕西师范大学 |
携带锌指核酸酶表达元件和供体dna的腺病毒及其构建方法和应用
|
JP2016500254A
(ja)
*
|
2012-12-05 |
2016-01-12 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
代謝疾患の調節のための方法および組成物
|
PL3138910T3
(pl)
|
2012-12-06 |
2018-01-31 |
Sigma Aldrich Co Llc |
Oparta na CRISPR modyfikacja i regulacja genomu
|
MX2015007574A
(es)
|
2012-12-13 |
2015-10-22 |
Dow Agrosciences Llc |
Gen de precision dirigido a un locus particular en el maiz.
|
JP6392245B2
(ja)
|
2012-12-18 |
2018-09-19 |
ノバルティス アーゲー |
遺伝子改変哺乳動物細胞における治療用タンパク質の産生
|
EP2938184B1
(en)
|
2012-12-27 |
2018-10-31 |
Keygene N.V. |
Method for removing genetic linkage in a plant
|
EP2958990B1
(en)
|
2013-02-20 |
2019-10-16 |
Regeneron Pharmaceuticals, Inc. |
Genetic modification of rats
|
EP2958996B1
(en)
|
2013-02-25 |
2019-10-16 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
US10329574B2
(en)
|
2013-03-12 |
2019-06-25 |
E I Du Pont De Nemours And Company |
Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
|
ES2786253T3
(es)
|
2013-03-14 |
2020-10-09 |
Immusoft Corp |
Métodos para la diferenciación y transducción in vitro de células b de memoria con vectores virales pseudotipados vsv-g
|
WO2014150624A1
(en)
|
2013-03-14 |
2014-09-25 |
Caribou Biosciences, Inc. |
Compositions and methods of nucleic acid-targeting nucleic acids
|
CA2906970C
(en)
|
2013-03-21 |
2021-05-18 |
Ospedale San Raffaele Srl |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
CN105263312A
(zh)
|
2013-04-05 |
2016-01-20 |
美国陶氏益农公司 |
用于在植物基因组内整合外源序列的方法和组合物
|
HUE040575T2
(hu)
|
2013-04-16 |
2019-03-28 |
Regeneron Pharma |
A patkány genom célzott módosítása
|
US10604771B2
(en)
*
|
2013-05-10 |
2020-03-31 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
CN105683376A
(zh)
|
2013-05-15 |
2016-06-15 |
桑格摩生物科学股份有限公司 |
用于治疗遗传病状的方法和组合物
|
JP2016521561A
(ja)
*
|
2013-06-14 |
2016-07-25 |
セレクティス |
植物における非トランスジェニックのゲノム編集のための方法
|
US11306328B2
(en)
|
2013-07-26 |
2022-04-19 |
President And Fellows Of Harvard College |
Genome engineering
|
WO2015017866A1
(en)
|
2013-08-02 |
2015-02-05 |
Enevolv, Inc. |
Processes and host cells for genome, pathway, and biomolecular engineering
|
JP6588438B2
(ja)
|
2013-08-28 |
2019-10-09 |
サンガモ セラピューティクス, インコーポレイテッド |
Dna結合ドメインと切断ドメインとを連結するための組成物
|
WO2015034885A1
(en)
|
2013-09-04 |
2015-03-12 |
Dow Agrosciences Llc |
Rapid targeting analysis in crops for determining donor insertion
|
CN110713995B
(zh)
|
2013-10-17 |
2023-08-01 |
桑格摩生物科学股份有限公司 |
用于核酸酶介导的基因组工程改造的递送方法和组合物
|
US10117899B2
(en)
|
2013-10-17 |
2018-11-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
|
CN105723222B
(zh)
|
2013-10-23 |
2019-01-22 |
吉尼亚科技公司 |
使用纳米孔的高速分子感测
|
US9322062B2
(en)
|
2013-10-23 |
2016-04-26 |
Genia Technologies, Inc. |
Process for biosensor well formation
|
US10233465B2
(en)
|
2013-11-04 |
2019-03-19 |
Dow Agrosciences Llc |
Optimal soybean loci
|
BR102014027438B1
(pt)
|
2013-11-04 |
2022-09-27 |
Dow Agrosciences Llc |
Molécula de ácido nucleico recombinante e método de produção de uma célula vegetal transgênica
|
MX360318B
(es)
|
2013-11-04 |
2018-10-29 |
Dow Agrosciences Llc |
Óptimos loci de maíz.
|
US9909131B2
(en)
|
2013-11-04 |
2018-03-06 |
Dow Agrosciences Llc |
Optimal soybean loci
|
NZ719477A
(en)
|
2013-11-11 |
2022-05-27 |
Sangamo Therapeutics Inc |
Methods and compositions for treating huntington’s disease
|
SI3068881T1
(sl)
|
2013-11-13 |
2019-05-31 |
Children's Medical Center Corporation |
Z nukleazo posredovano uravnavanje izražanja genov
|
CA2930590C
(en)
*
|
2013-11-15 |
2021-02-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Engineering neural stem cells using homologous recombination
|
ES2813367T3
(es)
|
2013-12-09 |
2021-03-23 |
Sangamo Therapeutics Inc |
Métodos y composiciones para ingeniería genómica
|
EP4349980A2
(en)
|
2013-12-11 |
2024-04-10 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for the targeted modification of a genome
|
MX2016007654A
(es)
|
2013-12-11 |
2017-08-15 |
Regeneron Pharma |
Metodos y composiciones para la modificacion dirigida de un genoma.
|
EP3080611B1
(en)
|
2013-12-13 |
2018-11-14 |
The General Hospital Corporation |
Soluble high molecular weight (hmw) tau species and applications thereof
|
US10774338B2
(en)
|
2014-01-16 |
2020-09-15 |
The Regents Of The University Of California |
Generation of heritable chimeric plant traits
|
PL3102673T3
(pl)
|
2014-02-03 |
2020-11-02 |
Sangamo Therapeutics, Inc. |
Sposoby i kompozycje do leczenia talasemii beta
|
US10036034B2
(en)
*
|
2014-02-13 |
2018-07-31 |
Nutech Ventures |
Sequences involved in plant yield and methods of using
|
CN113265394A
(zh)
|
2014-02-13 |
2021-08-17 |
宝生物工程(美国) 有限公司 |
从核酸的初始集合中耗尽靶分子的方法、以及用于实践其的组合物和试剂盒
|
JP6555683B2
(ja)
*
|
2014-02-19 |
2019-08-07 |
国立研究開発法人農業・食品産業技術総合研究機構 |
標的dnaに変異が導入された植物細胞、及びその製造方法
|
US10370680B2
(en)
|
2014-02-24 |
2019-08-06 |
Sangamo Therapeutics, Inc. |
Method of treating factor IX deficiency using nuclease-mediated targeted integration
|
WO2015129686A1
(ja)
|
2014-02-25 |
2015-09-03 |
国立研究開発法人 農業生物資源研究所 |
標的dnaに変異が導入された植物細胞、及びその製造方法
|
EP3613854A1
(en)
|
2014-03-05 |
2020-02-26 |
National University Corporation Kobe University |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
AU2015231353B2
(en)
|
2014-03-18 |
2020-11-05 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
US9522936B2
(en)
|
2014-04-24 |
2016-12-20 |
Sangamo Biosciences, Inc. |
Engineered transcription activator like effector (TALE) proteins
|
CN111647627A
(zh)
|
2014-04-28 |
2020-09-11 |
重组股份有限公司 |
多重基因编辑
|
CN106413760B
(zh)
|
2014-05-08 |
2020-01-14 |
桑格摩生物科学股份有限公司 |
用于治疗亨廷顿病的方法和组合物
|
EP3142707A4
(en)
|
2014-05-13 |
2018-02-21 |
Sangamo Therapeutics, Inc. |
Methods and compositions for prevention or treatment of a disease
|
WO2015188056A1
(en)
|
2014-06-05 |
2015-12-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease design
|
LT3152312T
(lt)
|
2014-06-06 |
2020-04-27 |
Regeneron Pharmaceuticals, Inc. |
Tikslinio lokuso modifikavimo būdai ir kompozicijos
|
CN106659290A
(zh)
*
|
2014-06-19 |
2017-05-10 |
高露洁-棕榄公司 |
口腔护理器具
|
HUE049405T2
(hu)
|
2014-06-23 |
2020-09-28 |
Regeneron Pharma |
Nukleáz-közvetített DNS-összeállítás
|
HUE041584T2
(hu)
|
2014-06-26 |
2019-05-28 |
Regeneron Pharma |
Célzott genetikai módosítások és alkalmazási módszerek és készítmények
|
WO2016005449A1
(en)
|
2014-07-08 |
2016-01-14 |
Vib Vzw |
Means and methods to increase plant yield
|
US9816074B2
(en)
|
2014-07-25 |
2017-11-14 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
US9757420B2
(en)
|
2014-07-25 |
2017-09-12 |
Sangamo Therapeutics, Inc. |
Gene editing for HIV gene therapy
|
US9616090B2
(en)
|
2014-07-30 |
2017-04-11 |
Sangamo Biosciences, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
WO2016044416A1
(en)
|
2014-09-16 |
2016-03-24 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease-mediated genome engineering and correction in hematopoietic stem cells
|
EA201790675A1
(ru)
|
2014-09-23 |
2017-08-31 |
Эгдженетикс, Инк. |
Материалы и способы для выведения животных с короткой шерстью
|
PL3207124T3
(pl)
|
2014-10-15 |
2019-11-29 |
Regeneron Pharma |
Sposoby i kompozycje do wytwarzania lub utrzymywania komórek pluripotencjalnych
|
PT3216867T
(pt)
|
2014-11-04 |
2020-07-16 |
Univ Kobe Nat Univ Corp |
Método para modificar a sequência de genoma para introduzir mutação específica a sequência de adn alvo por reação de remoção de bases, e complexo molecular nele utilizado
|
US20160160238A1
(en)
|
2014-11-12 |
2016-06-09 |
Recombinetics, Inc. |
Heterozygous modifications of tumor suppressor genes
|
KR102660362B1
(ko)
|
2014-11-17 |
2024-04-23 |
아디셋 바이오, 인크. |
조작된 감마 델타 t 세포
|
LT3221457T
(lt)
|
2014-11-21 |
2019-06-10 |
Regeneron Pharmaceuticals, Inc. |
Nukreipiančios genetinės modifikacijos būdai ir kompozicijos, naudojant suporuotas kreipiančiąsias rnr sekas
|
RU2020122439A
(ru)
|
2014-11-24 |
2020-09-24 |
Регенерон Фармасьютикалз, Инк. |
Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3
|
CN104450785A
(zh)
*
|
2014-12-08 |
2015-03-25 |
复旦大学 |
使用编码靶向核酸内切酶附着体载体的基因组编辑方法及试剂盒
|
US10889834B2
(en)
|
2014-12-15 |
2021-01-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing targeted transgene integration
|
RU2707137C2
(ru)
|
2014-12-19 |
2019-11-22 |
Регенерон Фармасьютикалз, Инк. |
Способы и композиции для нацеленной генетической модификации посредством одноэтапного множественного нацеливания
|
WO2016118726A2
(en)
|
2015-01-21 |
2016-07-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for identification of highly specific nucleases
|
ES2959608T3
(es)
|
2015-04-03 |
2024-02-27 |
Dana Farber Cancer Inst Inc |
Composición y métodos de edición del genoma de células B
|
WO2016176617A2
(en)
|
2015-04-29 |
2016-11-03 |
New York University |
Method for treating high-grade gliomas
|
US10179918B2
(en)
|
2015-05-07 |
2019-01-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increasing transgene activity
|
CA2984013A1
(en)
|
2015-05-12 |
2016-11-17 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
US9957501B2
(en)
|
2015-06-18 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
JP6837436B2
(ja)
|
2015-07-10 |
2021-03-03 |
中外製薬株式会社 |
内因性cd3遺伝子をヒトcd3遺伝子に置換した非ヒト動物
|
EP3322297A4
(en)
|
2015-07-13 |
2019-04-17 |
Sangamo Therapeutics, Inc. |
RELEASE METHOD AND COMPOSITIONS FOR NUCLEASE-DERIVED GENOMINE ENGINEERING
|
WO2017043656A1
(ja)
|
2015-09-09 |
2017-03-16 |
国立大学法人神戸大学 |
標的化したdna配列の核酸塩基を特異的に変換する、グラム陽性菌のゲノム配列の変換方法、及びそれに用いる分子複合体
|
JP6853257B2
(ja)
|
2015-09-23 |
2021-03-31 |
サンガモ セラピューティクス, インコーポレイテッド |
Httリプレッサー及びその使用
|
CA3006465A1
(en)
|
2015-10-27 |
2017-05-04 |
Recombinetics, Inc. |
Engineering of humanized car t-cells and platelets by genetic complementation
|
BR112018008519A2
(pt)
|
2015-10-28 |
2018-11-06 |
Sangamo Therapeutics Inc |
construtos específicos de fígado, cassetes de expressão de fator viii e métodos de uso dos mesmos
|
PT3368673T
(pt)
|
2015-10-29 |
2020-08-27 |
Amyris Inc |
Composições e métodos para a produção de mirceno
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
AU2016361350B2
(en)
|
2015-11-23 |
2023-04-06 |
Sangamo Therapeutics, Inc. |
Methods and compositions for engineering immunity
|
CN108495932B
(zh)
|
2015-11-27 |
2022-08-09 |
国立大学法人神户大学 |
用于特异性转换靶向dna序列的核酸碱基的单子叶植物的基因组序列的转换方法、及其使用的分子复合体
|
BR112018012235A2
(pt)
|
2015-12-18 |
2018-12-04 |
Sangamo Therapeutics Inc |
rompimento alvejado do receptor de células de mhc
|
AU2016369490C1
(en)
|
2015-12-18 |
2021-12-23 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the T cell receptor
|
AU2017207818B2
(en)
|
2016-01-15 |
2024-03-28 |
Regents Of The University Of Minnesota |
Methods and compositions for the treatment of neurologic disease
|
EP3769775A3
(en)
|
2016-02-02 |
2021-03-17 |
Sangamo Therapeutics, Inc. |
Compositions for linking dna-binding domains and cleavage domains
|
JP7001272B2
(ja)
|
2016-04-21 |
2022-01-19 |
国立大学法人神戸大学 |
ゲノム配列改変技術における変異導入効率の向上方法、及びそれに用いる分子複合体
|
WO2017197347A1
(en)
|
2016-05-12 |
2017-11-16 |
Adicet Bio, Inc. |
METHODS FOR SELECTIVE EXPANSION OF γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF
|
US11293021B1
(en)
|
2016-06-23 |
2022-04-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
EP3484870B1
(en)
|
2016-07-13 |
2022-11-16 |
Vertex Pharmaceuticals Incorporated |
Methods, compositions and kits for increasing genome editing efficiency
|
KR20190041476A
(ko)
|
2016-07-29 |
2019-04-22 |
리제너론 파마슈티칼스 인코포레이티드 |
C-절단된 피브릴린-1의 발현을 유도하는 돌연변이를 포함하는 마우스
|
US11193136B2
(en)
|
2016-08-09 |
2021-12-07 |
Vib Vzw |
Cellulose synthase inhibitors and mutant plants
|
CA3033372A1
(en)
|
2016-08-15 |
2018-02-22 |
Enevolv, Inc. |
Cell-free sensor systems
|
JP7125347B2
(ja)
*
|
2016-08-22 |
2022-08-24 |
中外製薬株式会社 |
ヒトgpc3ポリペプチドを発現する遺伝子改変非ヒト動物
|
CN110325635B
(zh)
|
2016-08-24 |
2023-12-26 |
桑格摩生物治疗股份有限公司 |
使用工程化的核酸酶调控基因表达
|
KR102455249B1
(ko)
|
2016-08-24 |
2022-10-17 |
상가모 테라퓨틱스, 인코포레이티드 |
가공된 표적 특이적 뉴클레아제
|
JP7256739B2
(ja)
|
2016-09-07 |
2023-04-12 |
サンガモ セラピューティクス, インコーポレイテッド |
肝臓遺伝子のモジュレーション
|
US20180084767A1
(en)
|
2016-09-21 |
2018-03-29 |
Recombinetics, Inc. |
Animal models for cardiomyopathy
|
CA3039014A1
(en)
|
2016-10-04 |
2018-04-12 |
Precision Biosciences, Inc. |
Co-stimulatory domains for use in genetically-modified cells
|
GB201617559D0
(en)
|
2016-10-17 |
2016-11-30 |
University Court Of The University Of Edinburgh The |
Swine comprising modified cd163 and associated methods
|
MX2019004487A
(es)
|
2016-10-20 |
2020-02-07 |
Sangamo Therapeutics Inc |
Metodos y composiciones para el tratamiento de la enfermedad de fabry.
|
US11020492B2
(en)
|
2016-10-31 |
2021-06-01 |
Sangamo Therapeutics, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
US20180142249A1
(en)
*
|
2016-11-21 |
2018-05-24 |
Dow Agrosciences Llc |
Site specific integration of a transgne using intra-genomic recombination via a non-homologous end joining repair pathway
|
ES2968892T3
(es)
|
2016-12-08 |
2024-05-14 |
Univ Case Western Reserve |
Métodos y composiciones para aumentar la producción de mielina funcional
|
CA3049980A1
(en)
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
CN118006597A
(zh)
|
2017-03-22 |
2024-05-10 |
国立大学法人神户大学 |
一种改变细胞中dna的靶向部位的方法以及用于该方法的复合体
|
AU2018256877B2
(en)
|
2017-04-28 |
2022-06-02 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
EP3619322A4
(en)
|
2017-05-03 |
2021-06-30 |
Sangamo Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODIFICATION OF A TRANSMEMBRANARY CONDUCTANCE REGULATORY GENE IN MUCOVISCIDOSIS (CFTR)
|
EP3634493A1
(en)
|
2017-05-08 |
2020-04-15 |
Precision BioSciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
EP3409104A1
(en)
|
2017-05-31 |
2018-12-05 |
Vilmorin et Cie |
Tomato plant resistant to tomato yellow leaf curl virus, powdery mildew, and nematodes
|
WO2020249996A1
(en)
|
2019-06-14 |
2020-12-17 |
Vilmorin & Cie |
Resistance in plants of solanum lycopersicum to the tobamovirus tomato brown rugose fruit virus
|
EP3409106A1
(en)
|
2017-06-01 |
2018-12-05 |
Vilmorin et Cie |
Tolerance in plants of solanum lycopersicum to the tobamovirus tomato brown rugose fruit virus (tbrfv)
|
SG11201911597YA
(en)
|
2017-06-05 |
2020-01-30 |
Regeneron Pharma |
B4galt1 variants and uses thereof
|
US11512287B2
(en)
|
2017-06-16 |
2022-11-29 |
Sangamo Therapeutics, Inc. |
Targeted disruption of T cell and/or HLA receptors
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
WO2019005957A1
(en)
|
2017-06-30 |
2019-01-03 |
Precision Biosciences, Inc. |
GENETICALLY MODIFIED T CELLS COMPRISING A MODIFIED INTRON IN THE ALPHA T CELL RECEPTOR GENE
|
HRP20220615T1
(hr)
|
2017-06-30 |
2022-06-24 |
Inscripta, Inc. |
Postupci, moduli, instrumenti i sustavi za automatiziranu obradu stanica
|
SG10201913144TA
(en)
|
2017-07-11 |
2020-03-30 |
Compass Therapeutics Llc |
Agonist antibodies that bind human cd137 and uses thereof
|
CN111182790A
(zh)
|
2017-07-31 |
2020-05-19 |
瑞泽恩制药公司 |
Crispr报告体非人类动物及其用途
|
AU2018309714A1
(en)
|
2017-07-31 |
2020-01-30 |
Regeneron Pharmaceuticals, Inc. |
Assessment of CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
|
AU2018309716A1
(en)
|
2017-07-31 |
2020-01-16 |
Regeneron Pharmaceuticals, Inc. |
Cas-transgenic mouse embryonic stem cells and mice and uses thereof
|
WO2019033053A1
(en)
|
2017-08-11 |
2019-02-14 |
Recombinetics, Inc. |
INDUCIBLE DISEASE MODELS, METHODS OF MAKING AND USING THEM IN TISSUE COMPLEMENTATION
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
EP3675623A1
(en)
|
2017-08-29 |
2020-07-08 |
KWS SAAT SE & Co. KGaA |
Improved blue aleurone and other segregation systems
|
EP3684389A4
(en)
|
2017-09-21 |
2021-06-16 |
Dana Farber Cancer Institute, Inc. |
INSULATION, PRESERVATION, COMPOSITIONS AND USES OF EXTRACTS FROM JUSTICIA PLANTS
|
EP4276185A3
(en)
|
2017-09-29 |
2024-02-21 |
Regeneron Pharmaceuticals, Inc. |
Rodents comprising a humanized ttr locus and methods of use
|
US10443074B2
(en)
|
2017-09-30 |
2019-10-15 |
Inscripta, Inc. |
Modification of cells by introduction of exogenous material
|
EP3692057B9
(en)
|
2017-10-03 |
2023-10-04 |
Precision BioSciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
WO2019089753A2
(en)
|
2017-10-31 |
2019-05-09 |
Compass Therapeutics Llc |
Cd137 antibodies and pd-1 antagonists and uses thereof
|
WO2019089913A1
(en)
|
2017-11-01 |
2019-05-09 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
KR20200079539A
(ko)
|
2017-11-09 |
2020-07-03 |
상가모 테라퓨틱스, 인코포레이티드 |
시토카인 유도성 sh2-함유 단백질 (cish) 유전자의 유전자 변형
|
WO2019099744A1
(en)
|
2017-11-15 |
2019-05-23 |
Adicet Bio, Inc. |
METHODS FOR SELECTIVE EXPANSION OF δ3 γδ T-CELL POPULATIONS AND COMPOSITIONS THEREOF
|
EP3713961A2
(en)
|
2017-11-20 |
2020-09-30 |
Compass Therapeutics LLC |
Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof
|
EP3715454A4
(en)
|
2017-11-22 |
2021-08-18 |
National University Corporation Kobe University |
COMPLEX FOR SAFE GENE EDITION WITH LOW SIDE EFFECTS, AND NUCLEIC ACID CODING THIS
|
EP3740479A1
(en)
|
2018-01-17 |
2020-11-25 |
Vertex Pharmaceuticals Incorporated |
Dna-pk inhibitors
|
CN111757876B
(zh)
|
2018-01-17 |
2024-03-22 |
沃泰克斯药物股份有限公司 |
Dna-pk抑制剂
|
EA202091707A1
(ru)
|
2018-01-17 |
2020-12-02 |
Вертекс Фармасьютикалз Инкорпорейтед |
Хиноксалиноновые соединения, композиции, способы и наборы для повышения эффективности редактирования генома
|
AU2019218118A1
(en)
|
2018-02-08 |
2020-08-13 |
Sangamo Therapeutics, Inc. |
Engineered target specific nucleases
|
CA3091143A1
(en)
|
2018-02-15 |
2019-08-22 |
Memorial Sloan-Kettering Cancer Center |
Foxp3 targeting agent compositions and methods of use for adoptive cell therapy
|
RU2020133851A
(ru)
|
2018-03-16 |
2022-04-19 |
Иммьюсофт Корпорейшн |
B-клетки, генетически модифицированные для секреции фоллистатина, и способы их применения для лечения связанных с фоллистатином заболеваний, состояний, нарушений и для увеличения роста и силы мышц
|
CA3089331A1
(en)
|
2018-03-19 |
2019-09-26 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using crispr/cas systems
|
JP6727680B2
(ja)
|
2018-03-26 |
2020-07-22 |
国立大学法人神戸大学 |
細胞の有する二本鎖dnaの標的部位を改変する方法
|
EP3775159A4
(en)
|
2018-03-29 |
2022-01-19 |
Inscripta, Inc. |
AUTOMATED REGULATION OF CELL GROWTH RATES FOR INDUCTION AND TRANSFORMATION
|
MA52207A
(fr)
|
2018-04-05 |
2021-02-17 |
Editas Medicine Inc |
Lymphocytes t exprimant un récepteur recombinant, polynucléotides et procédés associés
|
RU2020135966A
(ru)
|
2018-04-05 |
2022-05-06 |
Джуно Терапьютикс, Инк. |
Способы получения клеток, экспрессирующих рекомбинантный рецептор, и родственные композиции
|
WO2019200004A1
(en)
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
JP7332622B2
(ja)
|
2018-04-18 |
2023-08-23 |
サンガモ セラピューティクス, インコーポレイテッド |
ハンチンチン(htt)の調節のためのジンクフィンガータンパク質組成物
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
WO2019209926A1
(en)
|
2018-04-24 |
2019-10-31 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
GB201809273D0
(en)
|
2018-06-06 |
2018-07-25 |
Vib Vzw |
Novel mutant plant cinnamoyl-coa reductase proteins
|
EP3831946A4
(en)
|
2018-07-31 |
2022-08-10 |
The University of Tokyo |
METHOD FOR MEASURING MEMBRANE PROTEIN ACTIVITY
|
CN112585266A
(zh)
|
2018-08-07 |
2021-03-30 |
摩大力斯医疗株式会社 |
新型转录激活物
|
CN109097370A
(zh)
*
|
2018-08-08 |
2018-12-28 |
华南农业大学 |
一种调控茶树茸毛形成的方法
|
EP3607819A1
(en)
|
2018-08-10 |
2020-02-12 |
Vilmorin et Cie |
Resistance to xanthomonas campestris pv. campestris (xcc) in cauliflower
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
IL292273B2
(en)
|
2018-08-14 |
2023-10-01 |
Inscripta Inc |
Devices, modules and methods for improved detection of edited sequences in living cells
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
KR20210049124A
(ko)
|
2018-08-23 |
2021-05-04 |
상가모 테라퓨틱스, 인코포레이티드 |
조작된 표적 특이적 염기 편집기
|
US11708569B2
(en)
|
2018-08-29 |
2023-07-25 |
University Of Copenhagen |
Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase having low mannose-6-phosphate and high sialic acid
|
CA3108892A1
(en)
|
2018-08-30 |
2020-04-23 |
Inscripta, Inc. |
Improved detection of nuclease edited sequences in automated modules and instruments
|
CN113015741A
(zh)
|
2018-09-18 |
2021-06-22 |
桑格摩生物治疗股份有限公司 |
程序性细胞死亡1(pd1)特异性核酸酶
|
CN113166754A
(zh)
|
2018-10-16 |
2021-07-23 |
蓝色等位基因有限责任公司 |
用于将dna靶向插入基因中的方法
|
US11214781B2
(en)
|
2018-10-22 |
2022-01-04 |
Inscripta, Inc. |
Engineered enzyme
|
WO2020086475A1
(en)
|
2018-10-22 |
2020-04-30 |
Inscripta, Inc. |
Engineered enzymes
|
MX2021005594A
(es)
|
2018-11-13 |
2021-10-22 |
Compass Therapeutics Llc |
Constructos multiespecificos de union contra moleculas de puntos de control y usos de los mismos.
|
KR20210094609A
(ko)
|
2018-11-28 |
2021-07-29 |
포티 세븐, 인코포레이티드 |
절제 레짐에 대해 저항성인 유전적으로 변형된 hspc
|
EP3890757A1
(en)
|
2018-12-03 |
2021-10-13 |
Adicet Bio Inc. |
Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
GB201820109D0
(en)
|
2018-12-11 |
2019-01-23 |
Vib Vzw |
Plants with a lignin trait and udp-glycosyltransferase mutation
|
IL301193A
(en)
|
2018-12-20 |
2023-05-01 |
Regeneron Pharma |
Nuclease-mediated repeat expansion
|
EP3898661A1
(en)
|
2018-12-21 |
2021-10-27 |
Precision BioSciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
JP2022517783A
(ja)
|
2019-01-11 |
2022-03-10 |
アクイタス セラピューティクス インコーポレイテッド |
活性剤の脂質ナノ粒子送達のための脂質
|
JP2022519410A
(ja)
|
2019-02-06 |
2022-03-24 |
サンガモ セラピューティクス, インコーポレイテッド |
ムコ多糖症i型の処置のための方法
|
US11001831B2
(en)
|
2019-03-25 |
2021-05-11 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
EP3947691A4
(en)
|
2019-03-25 |
2022-12-14 |
Inscripta, Inc. |
SIMULTANEOUS MULTIPLEX GENOME EDITING IN A YEAST
|
MA55531A
(fr)
|
2019-04-02 |
2022-02-09 |
Sangamo Therapeutics Inc |
Procédés pour le traitement de béta-thalassémie
|
CN113993999B
(zh)
|
2019-04-03 |
2022-11-22 |
精密生物科学公司 |
包含microRNA适应的shRNA(shRNAmiR)的遗传修饰的免疫细胞
|
AU2020256225A1
(en)
|
2019-04-03 |
2021-09-02 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
|
IL286917B
(en)
|
2019-04-04 |
2022-09-01 |
Regeneron Pharma |
Methods for scar-free insertion of targeted modifications into targeted vectors
|
IL286905B1
(en)
|
2019-04-04 |
2024-02-01 |
Regeneron Pharma |
Non-human animals containing the human coagulation factor 12 locus
|
WO2020204159A1
(ja)
|
2019-04-05 |
2020-10-08 |
国立大学法人大阪大学 |
ノックイン細胞の作製方法
|
WO2020206231A1
(en)
|
2019-04-05 |
2020-10-08 |
Precision Biosciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
WO2020223571A1
(en)
|
2019-05-01 |
2020-11-05 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified cd247 locus, related polynucleotides and methods
|
CN114025788A
(zh)
|
2019-05-01 |
2022-02-08 |
朱诺治疗学股份有限公司 |
从经修饰的tgfbr2基因座表达重组受体的细胞、相关多核苷酸和方法
|
EP3801011A1
(en)
|
2019-06-04 |
2021-04-14 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
|
AU2020288623A1
(en)
|
2019-06-06 |
2022-01-06 |
Inscripta, Inc. |
Curing for recursive nucleic acid-guided cell editing
|
KR20220017939A
(ko)
|
2019-06-07 |
2022-02-14 |
리제너론 파마슈티칼스 인코포레이티드 |
인간화 알부민 좌위를 포함하는 비-인간 동물
|
AU2020290509A1
(en)
|
2019-06-14 |
2021-11-11 |
Regeneron Pharmaceuticals, Inc. |
Models of tauopathy
|
CN114008070A
(zh)
|
2019-06-21 |
2022-02-01 |
因思科瑞普特公司 |
导致大肠杆菌赖氨酸产量增加的全基因组合理设计的突变
|
WO2020254850A1
(en)
|
2019-06-21 |
2020-12-24 |
Vilmorin & Cie |
Improvement of quality and permanence of green color of peppers at maturity and over-maturity
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
CN114787358A
(zh)
|
2019-07-18 |
2022-07-22 |
罗切斯特大学 |
细胞的细胞类型选择性免疫保护
|
WO2021016608A1
(en)
|
2019-07-25 |
2021-01-28 |
Precision Biosciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
WO2021019272A1
(en)
|
2019-07-31 |
2021-02-04 |
Vilmorin & Cie |
Tolerance to tolcndv in cucumber
|
CA3148179A1
(en)
|
2019-08-20 |
2021-02-25 |
Bruce J. Mccreedy Jr. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
KR20220097414A
(ko)
|
2019-11-08 |
2022-07-07 |
리제너론 파마슈티칼스 인코포레이티드 |
X-연관 연소 망막층간분리 치료법을 위한 crispr 및 aav 전략
|
WO2021094805A1
(en)
|
2019-11-14 |
2021-05-20 |
Vilmorin & Cie |
Resistance to acidovorax valerianellae in corn salad
|
US11203762B2
(en)
|
2019-11-19 |
2021-12-21 |
Inscripta, Inc. |
Methods for increasing observed editing in bacteria
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
US20230036065A1
(en)
|
2019-12-06 |
2023-02-02 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
AU2020402526A1
(en)
|
2019-12-10 |
2022-06-09 |
Inscripta, Inc. |
Novel mad nucleases
|
US10704033B1
(en)
|
2019-12-13 |
2020-07-07 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
US11008557B1
(en)
|
2019-12-18 |
2021-05-18 |
Inscripta, Inc. |
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
WO2021154706A1
(en)
|
2020-01-27 |
2021-08-05 |
Inscripta, Inc. |
Electroporation modules and instrumentation
|
WO2021158915A1
(en)
|
2020-02-06 |
2021-08-12 |
Precision Biosciences, Inc. |
Recombinant adeno-associated virus compositions and methods for producing and using the same
|
EP4114946A1
(en)
|
2020-03-04 |
2023-01-11 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for sensitization of tumor cells to immune therapy
|
US20230102342A1
(en)
|
2020-03-23 |
2023-03-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
WO2021202513A1
(en)
|
2020-03-31 |
2021-10-07 |
Elo Life Systems |
Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
US20230212613A1
(en)
|
2020-05-06 |
2023-07-06 |
Cellectis S.A. |
Methods for targeted insertion of exogenous sequences in cellular genomes
|
AU2021269103A1
(en)
|
2020-05-06 |
2022-12-15 |
Cellectis S.A. |
Methods to genetically modify cells for delivery of therapeutic proteins
|
WO2021231259A1
(en)
|
2020-05-11 |
2021-11-18 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
CN115835873A
(zh)
|
2020-05-13 |
2023-03-21 |
朱诺治疗学股份有限公司 |
用于产生表达重组受体的供体分批细胞的方法
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
WO2021245435A1
(en)
|
2020-06-03 |
2021-12-09 |
Vilmorin & Cie |
Melon plants resistant to scab disease, aphids and powdery mildew
|
CN115867129A
(zh)
|
2020-06-05 |
2023-03-28 |
维尔莫林公司 |
番茄植物对ToBRFV的抗性
|
KR20230042283A
(ko)
|
2020-06-26 |
2023-03-28 |
주노 테라퓨틱스 게엠베하 |
재조합 수용체를 조건부로 발현하는 조작된 t 세포, 관련된 폴리뉴클레오티드 및 방법
|
EP4182297A1
(en)
|
2020-07-16 |
2023-05-24 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
EP4192875A1
(en)
|
2020-08-10 |
2023-06-14 |
Precision BioSciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
WO2022050413A1
(ja)
|
2020-09-04 |
2022-03-10 |
国立大学法人神戸大学 |
小型化シチジンデアミナーゼを含む二本鎖dnaの改変用複合体
|
US11299731B1
(en)
|
2020-09-15 |
2022-04-12 |
Inscripta, Inc. |
CRISPR editing to embed nucleic acid landing pads into genomes of live cells
|
IL301846A
(en)
|
2020-10-02 |
2023-06-01 |
Vilmorin & Cie |
A hotel with an extended shelf life
|
US20230365995A1
(en)
|
2020-10-07 |
2023-11-16 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
MX2023004761A
(es)
|
2020-10-23 |
2023-07-17 |
Elo Life Systems Inc |
Metodos para producir plantas de vainilla con mejor sabor y produccion agronomica.
|
CN116802203A
(zh)
|
2020-11-04 |
2023-09-22 |
朱诺治疗学股份有限公司 |
从经修饰的恒定cd3免疫球蛋白超家族链基因座表达嵌合受体的细胞、相关多核苷酸和方法
|
EP4242237A1
(en)
|
2020-11-06 |
2023-09-13 |
Editforce, Inc. |
Foki nuclease domain variant
|
US11512297B2
(en)
|
2020-11-09 |
2022-11-29 |
Inscripta, Inc. |
Affinity tag for recombination protein recruitment
|
US20240049668A1
(en)
|
2020-12-03 |
2024-02-15 |
Vilmorin & Cie |
Tomato plants resistant to tobrfv, tmv, tomv and tommv and corresponding resistance genes
|
AU2021415461A1
(en)
|
2021-01-04 |
2023-08-17 |
Inscripta, Inc. |
Mad nucleases
|
EP4274890A1
(en)
|
2021-01-07 |
2023-11-15 |
Inscripta, Inc. |
Mad nucleases
|
EP4284823A1
(en)
|
2021-01-28 |
2023-12-06 |
Precision BioSciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
US11884924B2
(en)
|
2021-02-16 |
2024-01-30 |
Inscripta, Inc. |
Dual strand nucleic acid-guided nickase editing
|
TW202305118A
(zh)
|
2021-03-23 |
2023-02-01 |
美商艾歐凡斯生物治療公司 |
腫瘤浸潤淋巴球之cish基因編輯及其在免疫療法中之用途
|
WO2022208489A1
(en)
|
2021-04-02 |
2022-10-06 |
Vilmorin & Cie |
Semi-determinate or determinate growth habit trait in cucurbita
|
IL282597B
(en)
*
|
2021-04-22 |
2022-08-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Birds for creating female offspring and methods for creating them
|
WO2022226316A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Compositions and methods for generating male sterile plants
|
EP4337769A1
(en)
|
2021-05-10 |
2024-03-20 |
SQZ Biotechnologies Company |
Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
KR20240027676A
(ko)
|
2021-06-02 |
2024-03-04 |
라이엘 이뮤노파마, 인크. |
Nr4a3-결핍 면역 세포 및 이의 용도
|
WO2023012325A1
(en)
|
2021-08-06 |
2023-02-09 |
Vilmorin & Cie |
Resistance to leveillula taurica in pepper
|
JP7125727B1
(ja)
|
2021-09-07 |
2022-08-25 |
国立大学法人千葉大学 |
核酸配列改変用組成物および核酸配列の標的部位を改変する方法
|
KR20240055084A
(ko)
|
2021-09-13 |
2024-04-26 |
라이프 테크놀로지스 코포레이션 |
유전자 편집 도구
|
WO2023064924A1
(en)
|
2021-10-14 |
2023-04-20 |
Codiak Biosciences, Inc. |
Modified producer cells for extracellular vesicle production
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
AU2022371430A1
(en)
|
2021-10-19 |
2024-05-30 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
WO2023076897A1
(en)
|
2021-10-25 |
2023-05-04 |
Fios Therapeutics, Llc |
Viable galactosyltransferase knock-out sheep and related methods
|
AU2022379633A1
(en)
|
2021-10-27 |
2024-04-11 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for expressing factor ix for hemophilia b therapy
|
CA3237482A1
(en)
|
2021-11-03 |
2023-05-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Precise genome editing using retrons
|
CA3237696A1
(en)
|
2021-11-08 |
2023-05-11 |
Progentos Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023091910A1
(en)
|
2021-11-16 |
2023-05-25 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
GB202117314D0
(en)
|
2021-11-30 |
2022-01-12 |
Clarke David John |
Cyclic nucleic acid fragmentation
|
CA3238939A1
(en)
|
2021-12-08 |
2023-06-15 |
Gaurang Patel |
Mutant myocilin disease model and uses thereof
|
GB202118058D0
(en)
|
2021-12-14 |
2022-01-26 |
Univ Warwick |
Methods to increase yields in crops
|
WO2023129974A1
(en)
|
2021-12-29 |
2023-07-06 |
Bristol-Myers Squibb Company |
Generation of landing pad cell lines
|
WO2023131616A1
(en)
|
2022-01-05 |
2023-07-13 |
Vib Vzw |
Means and methods to increase abiotic stress tolerance in plants
|
WO2023131637A1
(en)
|
2022-01-06 |
2023-07-13 |
Vib Vzw |
Improved silage grasses
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2023144199A1
(en)
|
2022-01-26 |
2023-08-03 |
Vib Vzw |
Plants having reduced levels of bitter taste metabolites
|
TW202332767A
(zh)
|
2022-02-02 |
2023-08-16 |
美商雷傑納榮製藥公司 |
用於治療龐貝氏症之抗TfR:GAA及抗CD63:GAA插入
|
WO2023150798A1
(en)
|
2022-02-07 |
2023-08-10 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for defining optimal treatment timeframes in lysosomal disease
|
WO2023154861A1
(en)
|
2022-02-11 |
2023-08-17 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for screening 4r tau targeting agents
|
WO2023178297A1
(en)
|
2022-03-18 |
2023-09-21 |
Obsidian Therapeutics, Inc. |
Compact drug responsive domains for regulation of function/abundance and delivery of polypeptide payloads
|
EP4256950A1
(en)
|
2022-04-06 |
2023-10-11 |
Vilmorin et Cie |
Tolerance to cgmmv in cucumber
|
WO2023220603A1
(en)
|
2022-05-09 |
2023-11-16 |
Regeneron Pharmaceuticals, Inc. |
Vectors and methods for in vivo antibody production
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
GB2621813A
(en)
|
2022-06-30 |
2024-02-28 |
Univ Newcastle |
Preventing disease recurrence in Mitochondrial replacement therapy
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
WO2024031053A1
(en)
|
2022-08-05 |
2024-02-08 |
Regeneron Pharmaceuticals, Inc. |
Aggregation-resistant variants of tdp-43
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2024064952A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells overexpressing c-jun
|
WO2024064958A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
WO2024073606A1
(en)
|
2022-09-28 |
2024-04-04 |
Regeneron Pharmaceuticals, Inc. |
Antibody resistant modified receptors to enhance cell-based therapies
|
WO2024077174A1
(en)
|
2022-10-05 |
2024-04-11 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
WO2024098002A1
(en)
|
2022-11-04 |
2024-05-10 |
Regeneron Pharmaceuticals, Inc. |
Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|